Dr. Mark C Tekrony is a Reston, Virginia based neurologist with 25 years of experience in Neuromuscular Medicine. He completed his graduation from Rutgers New Jersey Medical School in 1999. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Mark C Tekrony is 0101232613 for Neurology in Virginia. His current practice location is 1830 Town Center Dr Ste 305, Reston. Patients can reach him at 703-876-0800 or can fax him at 703-876-0866. Dr. Mark C Tekrony is PH.D., M.D. in Neuromuscular Medicine and his NPI number (Unique professional ID assigned by NPPES) is 1386613826. Dr. Mark C Tekrony is a neurologist or child neurologist who specializes in the diagnosis and management of disorders of nerve, muscle or neuromuscular junction, including amyotrophic lateral sclerosis, peripheral neuropathies (e.g., diabetic and immune mediated neuropathies), various muscular dystrophies, congenital and acquired myopathies, inflammatory myopathies (e.g., polymyositis, inclusion body myositis) and neuromuscular transmission disorders (e.g., myasthenia gravis, Lambert-Eaton myasthenic syndrome).
Complete Profile:
Dr. Mark C Tekrony speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Mark C Tekrony
Specialization:
Neuromuscular Medicine
Gender:
Male
Credentials:
PH.D., M.D.
Experience:
25+ years
Medical School Attended:
Rutgers New Jersey Medical School
Graduation Year:
1999
Accepts Medicare Assignment:
Yes
Practice Address:
1830 Town Center Dr Ste 305, Reston, Virginia, 20190-3217
Phone:
703-876-0800
Fax:
703-876-0866
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
2668467747
Enrollment ID:
I20040417000610
NPI Number:
1386613826
NPI Enumeration Date:
16 Mar, 2006
NPI Last Update On:
08 Jun, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark C Tekrony are as mentioned below.
License Number
Specialization
State
Status
0101232613
Neurology
Virginia
Primary
0101232613
Neuromuscular Medicine
Virginia
Secondary
0101232613
Clinical Neurophysiology
Virginia
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(490107)
Reston, VA
Acute Care Hospital
(490063)
Falls church, VA
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Mark C Tekrony is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Inova Health Care Services (2466351093)
1294
Neurology Center Of Fairfax, Ltd (3577558659)
13
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Mark C Tekrony such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
010064414
Medicaid
Virginia
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Mark C Tekrony 3020 Hamaker Ct, Suite 400 Fairfax, Virginia
Zip:
22031-2238
Phone Number:
703-876-0800
Fax Number:
703-876-0866
Patients can reach Dr. Mark C Tekrony at 1830 Town Center Dr Ste 305, Reston, Virginia or can call to book an appointment on 703-876-0800.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.